The Lucerne company CargoRoll, a freight wagon portfolio company managed by Reichmuth & Co Investment Management, closed a EUR 135 million facilities agreement with a syndicate of renowned financial institutions led by UBS Switzerland acting as
Sika has announced yesterday that it agreed to sell MBCC Group’s chemical admixtures assets in England, the USA, Canada, Europe, Australia, and New Zealand (Disposal Perimeter) to private equity firm Cinven. The divestment of
MLL Legal has signed an agreement with Swiss-based Logol Group for the implementation of their ELLE legal software. “Focus on being a lawyer, let ELLE do the rest” is not only how the ELLE legal
Medartis, a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private founders of KeriMedical, a Geneva-based private company specializing in the development and manufacture of implants for hand
Kellerhals Carrard advised UNISERS, a Swiss semiconductor metrology company that identifies invisible defects caused by contamination in semiconductor materials, which raised $14 million in seed funding. The deal was led by Intel Capital, with participation from
Relai, a Switzerland-based Bitcoin-only investment platform, announced the closing of a USD 4.5 million financing. The round was led by ego death capital (EDC), with further participation from Timechain, Cabrit Capital and Lightning Ventures, as well
Bachem Holding successfully placed newly issued shares raising gross proceeds of approximately CHF 584 million by way of an accelerated bookbuilding to finance
As we have informed here, the private equity firm Argos Wityu has acquisted a majority stake in Norline, a leading provider of outsourcing services in the heating, ventilation, air conditioning and plumbing sector in Switzerland.
Credit Suisse and UBS signed a merger agreement, with UBS emerging as the surviving entity. With the combined market capitalization is approximately USD 65 billion, the merger follows negotiations between the two Swiss banks, prompted by
Basel-based orthopedic firm, Medartis, has successfully completed the acquisition of an additional 18% stake in Geneva-based implant manufacturer, KeriMedical, for approximately CHF 18 million. This deal will raise Medartis’ stake to 47%, further cementing the company’s commitment
